疑卷入“雀巢奶粉召回事件”，嘉必优收监管函

Core Viewpoint - The Shanghai Stock Exchange has issued a regulatory letter to Jiabiyou, urging the company to respond promptly and fulfill its information disclosure obligations, potentially linked to a recent global recall of infant formula by Nestlé [1][2]. Group 1: Regulatory Actions - Jiabiyou received a regulatory letter from the Shanghai Stock Exchange on January 12, 2026, regarding the need to respond to the exchange's inquiries and fulfill disclosure obligations [2]. - The specific content of the regulatory letter from the Shanghai Stock Exchange remains unclear, but it is speculated to be related to Nestlé's recent recall of infant formula products [2]. Group 2: Market Impact and Company Response - Following the recall incident, Jiabiyou's stock price fell by 14.62% to 20.5 CNY per share on January 8, marking a nine-month low since April 10, 2025 [5]. - As of January 12, 2026, Jiabiyou's stock was trading at 20.45 CNY per share, with a total market capitalization of 3.442 billion CNY [5]. Group 3: Company Profile and Product Information - Jiabiyou is identified as the largest supplier of Arachidonic Acid (ARA) in China and a significant player in the international market [4]. - The company's main products include ARA, Docosahexaenoic Acid (DHA), β-Carotene (BC), N-Acetylneuraminic Acid (SA), and other related compounds [4].